[go: up one dir, main page]

AR070984A1 - Cepa de lactobacillus rhamnosus - Google Patents

Cepa de lactobacillus rhamnosus

Info

Publication number
AR070984A1
AR070984A1 ARP090100975A ARP090100975A AR070984A1 AR 070984 A1 AR070984 A1 AR 070984A1 AR P090100975 A ARP090100975 A AR P090100975A AR P090100975 A ARP090100975 A AR P090100975A AR 070984 A1 AR070984 A1 AR 070984A1
Authority
AR
Argentina
Prior art keywords
lactobacillus rhamnosus
rhamnosus strain
strain
registered
present application
Prior art date
Application number
ARP090100975A
Other languages
English (en)
Inventor
Artem Khlebnikov
Gianfranco Grompone
Denis Thierry Saint
Isabelle Chambaud
Anne-Catherine Villain
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of AR070984A1 publication Critical patent/AR070984A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente solicitud se refiere a una cepa de Lactobacillus rhamnosus que posee propiedades antimicrobianas e inmunomoduladoras, así como a compuestos que contienen la mencionada cepa, registrada ante CNCM bajo el N° I-3690.
ARP090100975A 2008-03-19 2009-03-18 Cepa de lactobacillus rhamnosus AR070984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0801507A FR2928935B1 (fr) 2008-03-19 2008-03-19 Souche de lactobacillus rhamnosus.

Publications (1)

Publication Number Publication Date
AR070984A1 true AR070984A1 (es) 2010-05-19

Family

ID=39876532

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100975A AR070984A1 (es) 2008-03-19 2009-03-18 Cepa de lactobacillus rhamnosus

Country Status (14)

Country Link
US (1) US8697054B2 (es)
EP (1) EP2268792B1 (es)
JP (1) JP5539953B2 (es)
KR (1) KR101645741B1 (es)
CN (1) CN102016005B (es)
AR (1) AR070984A1 (es)
CA (1) CA2718833C (es)
CL (1) CL2009000649A1 (es)
ES (1) ES2544687T3 (es)
FR (1) FR2928935B1 (es)
MX (1) MX2010010256A (es)
PL (1) PL2268792T3 (es)
RU (1) RU2549699C2 (es)
WO (1) WO2009122042A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102858948B (zh) * 2010-01-08 2015-11-25 热尔韦·达诺尼公司 具有抗氧化作用的乳酸杆菌
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
EA024923B1 (ru) 2010-07-15 2016-11-30 Компани Жервэ Данон Применение марганца для селективной стимуляции роста lactobacillus casei в смешанных культурах
CN103436461B (zh) * 2010-12-08 2015-03-11 益擎生技股份有限公司 新颖乳酸菌株及其调节免疫反应的用途
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
US10487305B2 (en) * 2012-04-05 2019-11-26 London Health Sciences Centre Research Inc. Food grade bacteria for the removal of toxic compounds
WO2014072771A1 (en) 2012-11-12 2014-05-15 Compagnie Gervais Danone Lactobacillus rhamnosus strain for reducing body fat accumulation
US10022407B2 (en) * 2012-11-12 2018-07-17 Compagnie Gervais Danone Use of a lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance
US9649347B2 (en) * 2013-11-15 2017-05-16 Jiangnan University Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury
WO2015159125A1 (en) * 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis
WO2017050980A1 (en) * 2015-09-25 2017-03-30 N.V. Nutricia Lactobacillus rhamnosus and supernatants thereof for inhibition of pathogens
US11207358B2 (en) * 2016-12-16 2021-12-28 Compagnie Gervais Danone Probiotic composition comprising Lactobacillus rhamnosus and Lactobacillus paracasei and methods thereof
EP3589741A1 (en) * 2017-03-03 2020-01-08 Biomillenia SAS Microparticle for cultivating and testing cells
KR102166461B1 (ko) * 2020-03-10 2020-10-15 주식회사 종근당바이오 장관 면역조절 기능과 염증성 장 질환의 예방 또는 치료 활성을 갖는 락토바실러스 람노서스 균주
WO2021242057A1 (ko) * 2020-05-28 2021-12-02 주식회사 바이오뱅크힐링 락토바실러스 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102296286B1 (ko) * 2020-06-16 2021-09-01 주식회사 바이오뱅크힐링 락토바실러스 람노서스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN112538448B (zh) * 2020-12-25 2022-09-13 天津科技大学 一种从雪莲菌中定向筛选的具有益生特性的乳酸菌、筛选方法和应用
KR102443495B1 (ko) * 2021-07-28 2022-09-15 재단법인 농축산용미생물산업육성지원센터 신균주 락토바실러스 람노서스 cacc 612 및 이를 유효성분으로 함유하는 반려동물용 사료 조성물
CN114672441B (zh) * 2022-05-05 2023-04-07 华中农业大学 一种乳酸菌组合物及其应用
CN115011513A (zh) * 2022-06-08 2022-09-06 曾俊源 一种增强免疫并调解肠胃控制脂肪及减肥排毒的乳酸菌粉
WO2025032353A1 (en) 2023-08-04 2025-02-13 Compagnie Gervais Danone Symbiotic fermented milk products containing a probiotic and storage-stable in situ produced galacto-oligosaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI102807B1 (fi) 1994-08-25 1999-02-26 Valio Oy Lactobacillus rhamnosuksen käyttö elintarviketeollisuudessa klostridien estoon
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
TR200000451T2 (tr) * 1997-08-21 2000-06-21 New Zealand Dairy Board Bağışıklık arttırıcı laktik asit bakterileri.
RU2252770C2 (ru) * 2003-09-23 2005-05-27 Одушко Игорь Николаевич Лечебно-профилактическое средство "бионорм", способ его получения и способ его применения
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
KR100991456B1 (ko) * 2008-06-24 2010-11-04 목포대학교산학협력단 김치로부터 분리된 유산균 및 그의 용도

Also Published As

Publication number Publication date
RU2010142489A (ru) 2012-04-27
WO2009122042A3 (fr) 2009-11-26
ES2544687T3 (es) 2015-09-02
US20110059058A1 (en) 2011-03-10
RU2549699C2 (ru) 2015-04-27
EP2268792B1 (fr) 2015-05-13
JP2011515085A (ja) 2011-05-19
CN102016005B (zh) 2013-05-22
CL2009000649A1 (es) 2009-08-07
MX2010010256A (es) 2010-12-06
KR20110019355A (ko) 2011-02-25
WO2009122042A2 (fr) 2009-10-08
FR2928935A1 (fr) 2009-09-25
FR2928935B1 (fr) 2011-05-20
EP2268792A2 (fr) 2011-01-05
US8697054B2 (en) 2014-04-15
JP5539953B2 (ja) 2014-07-02
CA2718833A1 (fr) 2009-10-08
CA2718833C (fr) 2019-04-16
KR101645741B1 (ko) 2016-08-04
CN102016005A (zh) 2011-04-13
PL2268792T3 (pl) 2015-12-31
BRPI0909760A2 (pt) 2015-08-25

Similar Documents

Publication Publication Date Title
AR070984A1 (es) Cepa de lactobacillus rhamnosus
AR071330A1 (es) Cepa de lactobacillus paracasei subsp paracasei dotada de propiedades antimicrobianas e inmunomoduladoras
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
BR112012010923A2 (pt) cepa de bifidobactéria
EA201491848A1 (ru) Биозащита с использованием штаммов lactobacillus paracasei
AR085943A1 (es) Composicion antimicrobiana
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
CO7141405A2 (es) Uso de pro-fungicidas de uk-2a para el control de la sigatoka negra
IN2012DN00851A (es)
ES2531193T3 (es) Cepas de levadura y métodos de utilización de las mismas
EA201891030A3 (ru) Биозащита с применением штаммов lactobacillus rhamnosus
GB201217262D0 (en) Polymers of 8,9-Dihydrobenzo(DEF)Cabazole and their use as organic semiconductors
MY161868A (en) Anti-bv8 antibodies and uses thereof
PH12015501273A1 (en) Probiotic strains for the treatment and/or prevention of diarrhea
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
CL2013001315A1 (es) Composicion que comprende micro-organismo probioticos no replicantes extruidos.
SG190738A1 (en) Non-linear acene derivatives and their use as organic semiconductors
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
CR20140375A (es) Superficie
MX383473B (es) Empleo de probióticos en el incremento de la fertilidad masculina.
AU2011298391A8 (en) Substituted N-phenethyltriazoloneacetamides and uses thereof
MX2014001572A (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.
PH12014502244A1 (en) Novel separated bacillus linheniformis and probiotics using same
WO2011071289A3 (ko) 흡수성 재료 및 이를 이용한 식립체, 임플란트
RU2012108361A (ru) Штамм лактозосбраживающих бактерий enterococcus hirae вкпм в-9069 - продуцент молочной кислоты и пробиотиков

Legal Events

Date Code Title Description
FG Grant, registration